BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1435056)

  • 1. Spinally-mediated antinociception is induced in mice by an adenosine kinase-, but not by an adenosine deaminase-, inhibitor.
    Keil GJ; DeLander GE
    Life Sci; 1992; 51(19):PL171-6. PubMed ID: 1435056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive and anti-inflammatory properties of an adenosine kinase inhibitor and an adenosine deaminase inhibitor.
    Poon A; Sawynok J
    Eur J Pharmacol; 1999 Nov; 384(2-3):123-38. PubMed ID: 10611432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine kinase and adenosine deaminase inhibition modulate spinal adenosine- and opioid agonist-induced antinociception in mice.
    Keil GJ; DeLander GE
    Eur J Pharmacol; 1994 Dec; 271(1):37-46. PubMed ID: 7698211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine kinase inhibitors augment release of adenosine from spinal cord slices.
    Golembiowska K; White TD; Sawynok J
    Eur J Pharmacol; 1996 Jun; 307(2):157-62. PubMed ID: 8832217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral antinociceptive effect of an adenosine kinase inhibitor, with augmentation by an adenosine deaminase inhibitor, in the rat formalin test.
    Sawynok J; Reid A; Poon A
    Pain; 1998 Jan; 74(1):75-81. PubMed ID: 9514563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat.
    Poon A; Sawynok J
    Pain; 1998 Feb; 74(2-3):235-45. PubMed ID: 9520238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociception by adenosine analogs and an adenosine kinase inhibitor: dependence on formalin concentration.
    Poon A; Sawynok J
    Eur J Pharmacol; 1995 Nov; 286(2):177-84. PubMed ID: 8605954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of adenosine release from rat spinal cord by adenosine deaminase and adenosine kinase inhibitors.
    Golembiowska K; White TD; Sawynok J
    Brain Res; 1995 Nov; 699(2):315-20. PubMed ID: 8616636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of formalin-evoked adenosine release by an adenosine kinase inhibitor and an adenosine deaminase inhibitor in the rat hind paw: a microdialysis study.
    Liu XJ; White TD; Sawynok J
    Eur J Pharmacol; 2000 Nov; 408(2):143-52. PubMed ID: 11080520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-administration of adenosine kinase and deaminase inhibitors produces supra-additive potentiation of N-methyl-D-aspartate-evoked adenosine formation in cortex.
    Hebb MO; White TD
    Eur J Pharmacol; 1998 Mar; 344(2-3):121-5. PubMed ID: 9600645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of treatment with 3'-deoxyadenosine associated deoxycoformycin on hematological parameters and activity of adenosine deaminase in infected mice with Trypanosoma evansi.
    Dalla Rosa L; Da Silva AS; Ruchel JB; Gressler LT; Oliveira CB; França RT; Lopes ST; Leal DB; Monteiro SG
    Exp Parasitol; 2013 Oct; 135(2):357-62. PubMed ID: 23933282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine-mediated killing of cultured epithelial cancer cells.
    Barry CP; Lind SE
    Cancer Res; 2000 Apr; 60(7):1887-94. PubMed ID: 10766176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility.
    Zhang G; Franklin PH; Murray TF
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1415-24. PubMed ID: 8450475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity of cordycepin in combination with the adenosine deaminase inhibitor 2'-deoxycoformycin in beagle dogs.
    Rodman LE; Farnell DR; Coyne JM; Allan PW; Hill DL; Duncan KL; Tomaszewski JE; Smith AC; Page JG
    Toxicol Appl Pharmacol; 1997 Nov; 147(1):39-45. PubMed ID: 9356305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis in CD4+ prolymphocytic leukemia by deoxyadenosine and 2'-deoxycoformycin.
    Johnston JB; Lee K; Verburg L; Blondal J; Mowat MR; Israels LG; Begleiter A
    Leuk Res; 1992 Aug; 16(8):781-8. PubMed ID: 1528066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of viramidine to ribavirin in vivo by adenosine deaminase and its inhibition by 2'-deoxycoformycin.
    Wu JZ; Yeh LT; Lin CC; Hong Z
    Antivir Chem Chemother; 2006; 17(1):33-9. PubMed ID: 16542004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
    Bontemps F; Van den Berghe G
    Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of adenosine deaminase and adenosine kinase in regulating extracellular adenosine concentration in rat hippocampal slices.
    Lloyd HG; Fredholm BB
    Neurochem Int; 1995 Apr; 26(4):387-95. PubMed ID: 7633332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of ATP catabolism induced by deoxyadenosine and other nucleosides in adenosine deaminase-inhibited human erythrocytes.
    Bontemps F; Van den Berghe G
    Adv Exp Med Biol; 1989; 253B():267-74. PubMed ID: 2558538
    [No Abstract]   [Full Text] [Related]  

  • 20. Rat brain adenosine deaminase after 2'-deoxycoformycin administration: biochemical properties and evidence for reduced enzyme levels detected by 2'-[3H]deoxycoformycin ligand binding.
    Padua RA; Geiger JD; Delaney SM; Nagy JI
    J Neurochem; 1992 Feb; 58(2):421-9. PubMed ID: 1729390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.